KRAS and familial pancreatic carcinoma: Based on the observation that inhibiting 5-Lox can kill pancreatic cancer cells through apoptosis and block K-Ras signaling pathways, it was hypothesized that 5-Lox inhibition combined with gemcitabine could synergize to induce apoptosis and reduce the oncogenic phenotypes in pancreatic cancer cells.